PRE-MARKET
Aurobindo Pharma's revenue saw a 16% rise to Rs 9,150 crore, compared to Rs 7,868 crore in the preceding financial year.
Aurobindo Pharma Q1 Results: Profit Jumps 25%, Revenue Rises To Rs 9,150 Crore; Margins Improve
Impact Score
Market Sentiment
↑BullishPrimary Sectors
Aurobindo Pharma's revenue saw a 16% rise to Rs 9,150 crore, compared to Rs 7,868 crore in the preceding financial year.
Key Highlights
Aurobindo Pharma's revenue saw a 16% rise to Rs 9,150 crore, compared to Rs 7,868 crore in the preceding financial year..
Source
NDTV Profit
Published
1h ago
Impact Score
75 / 100
Category
Corporate Earnings
Positive near-term momentum expected in Corporate Earnings as market digests this development.
What this means
No linked events found.